Saturday 17 October 2026 Export NSPR’s income statement to Excel — free account

InspireMD, Inc.

InspireMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.0 million, up 28.1% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 34.6% and free cash flow fell 26.0%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

0.46 0.02 −4.17%

Follow NSPR

Alert me

Market cap: $22.3M
P/E: 0.0×
Fwd P/E: −2.5×
Dividend yield: —
F-score: 5/9
Altman Z: −2.61
Beneish M: −3.55
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.43

Total sells 0.10

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	1	4	—	—	—	—	7	—	—	—	—	—
Sell	—	—	1	—	—	—	—	—	—	—	—	—

Insider Ownership 60.94%

Capital & Financial Ratios $m

Market Cap 22.34

Revenue 10.84

Net Income (52.48)

Free Cash Flow (42.45)

Net Debt (30.42)

Current Ratio 3.80

Debt/Equity 0.00

P/E ratio 0.00

Fwd P/E (2.52)

P/S ratio 3.59

P/B ratio 1.24

Past 5Y EPS Growth —

This Y EPS Growth 19.30%

Next Y EPS Growth 21.20%

Next Y revenue growth 9.13%

Next 5Y EPS Growth 5.98%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 50.53%

10-year low 10-year high

P/B against its own 10 years 59.96%

10-year low 10-year high

EV/Sales against its own 10 years 34.61%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2023	Powerpack
2022	Powerpack
2021	Powerpack
2018	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	39	35	54	30
Receivables	2	2	3	2
Inventory	2	3	3	3
Other	—	—	—	—
	44	41	61	37

	2023	2024	2025	Q'26
Payables	6	8	11	10
ST’ Debt	—	—	—	—
Other	—	—	—	—
	6	8	11	10

Compound Annual Growth %

	10y	5y	3y
Sales	14.54%	29.29%	20.19%
Cash Flow	0.00%	0.00%	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	0.00%	35.33%	46.96%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	3	2	—	—	—
’25	2	2	3	3	9
’24	2	2	2	2	7
’23	1	2	2	2	6
’22	1	2	1	1	5
’21	1	1	1	1	4
’20	1	0	1	0	2

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(12)	(11)	—	—	—
’25	(9)	(8)	(9)	(9)	(35)
’24	(5)	(4)	(6)	(7)	(22)
’23	(5)	(3)	(4)	(4)	(16)
’22	(4)	(3)	(5)	(3)	(16)
’21	(4)	(3)	(4)	(3)	(13)
’20	(2)	(1)	(3)	(2)	(9)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(13)	(11)	—	—	—
’25	(9)	(9)	(9)	(10)	(37)
’24	(5)	(5)	(6)	(7)	(23)
’23	(5)	(3)	(4)	(4)	(17)
’22	(4)	(3)	(5)	(3)	(16)
’21	(4)	(3)	(4)	(3)	(14)
’20	(2)	(1)	(3)	(2)	(9)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.16)	(0.17)	—	—	—
’25	—	(0.26)	(0.17)	(0.14)	(0.76)
’24	(0.21)	(0.22)	(0.16)	(0.19)	(0.76)
’23	(0.53)	(0.24)	(0.15)	(0.16)	(0.82)
’22	(0.57)	(0.59)	(0.58)	(0.60)	(2.35)
’21	(0.53)	(0.46)	(0.53)	(0.53)	(2.03)
’20	(6.45)	(3.00)	(0.90)	(1.50)	(6.90)

Fiscal quarters ending in the months shown.

value withheld pending a data check

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	37,012.50	3,150.00	97.50	11.10	4.20	2.83	0.81	0.84	1.81	1.59	Analyst estimates 2026–2028 Powerpack
	High	623,437.50	104,212.50	8,400.00	172.50	24.60	22.20	3.33	3.85	3.42	3.80
People
People	Employees	34	36	43	48	48	52	56	66	86	127
	Revenue/emp, $m	0.06	0.08	0.08	0.08	0.05	0.09	0.09	0.09	0.08	0.07
Income, $m
Income, $m	Revenue	2	3	4	4	2	4	5	6	7	9
	Gross margin, %	5.39	21.19	27.63	20.32	3.34	16.77	21.60	29.12	21.49	29.50
	EBT	(8)	(8)	(7)	(10)	(11)	(15)	(18)	(20)	(32)	(49)
	EBT margin, %	(446.67)	(304.64)	(201.06)	(269.17)	(424.14)	(330.88)	(357.05)	(319.92)	(455.79)	(542.63)
	Net income	(8)	(8)	(7)	(10)	(11)	(15)	(18)	(20)	(32)	(49)
	Depreciation	0	0	0	0	0	0	0	0	0	0
Per share, $
Per share, $	Revenue	18,940.00	5,522.00	116.92	26.69	1.64	0.61	0.66	0.26	0.17	0.14
	Earnings	(155,429.30)	(26,221.89)	(247.38)	(71.96)	(6.90)	(2.03)	(2.35)	(0.82)	(0.76)	(0.76)
	Cash flow	(74,950.00)	(16,262.00)	(246.95)	(70.37)	(6.00)	(1.80)	(1.97)	(0.67)	(0.52)	(0.55)
	Capex	(490.00)	(516.00)	(2.18)	(2.04)	(0.04)	(0.05)	(0.06)	(0.02)	(0.03)	(0.03)
	Free cash flow	(75,440.00)	(16,778.00)	(249.12)	(72.41)	(6.05)	(1.85)	(2.03)	(0.69)	(0.55)	(0.57)
	Book value	40,450.00	5,454.00	284.51	38.62	8.04	4.56	2.21	1.63	0.86	0.86
	Shares, m	0	0	0	0	2	7	8	24	42	64
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	3.27	0.62	1.03	0.61	3.10	4.94	1.40	10.60	15.73	12.75
	P/B	1.53	0.63	0.42	0.42	0.63	0.66	0.42	1.66	3.06	2.07
	EV/Sales	1.30	0.64	(0.53)	0.14	(0.46)	(1.80)	(1.31)	4.92	11.33	7.14
	EV/FCF	(0.33)	(0.21)	0.25	(0.05)	0.12	0.60	0.42	(1.82)	(3.41)	(1.74)
Cash, $m
Cash, $m	Operating cash flow	(7)	(8)	(8)	(10)	(9)	(13)	(16)	(16)	(22)	(35)
	Capex	0	0	0	0	0	0	0	0	(1)	(2)
	Free cash flow	(8)	(8)	(8)	(10)	(9)	(14)	(16)	(17)	(23)	(37)
Balance, $m
Balance, $m	Working capital	4	3	8	5	12	33	16	38	33	51
	Total debt	3	—	—	1	1	1	2	—	—	—
	Net debt	(5)	(4)	(9)	(6)	(13)	(34)	(18)	(39)	(35)	(54)
	Shareholders’ equity	4	3	9	5	12	34	17	40	36	55
Returns, %
Returns, %	ROA	(112.04)	(167.92)	(78.72)	(90.58)	(76.25)	(51.90)	(57.46)	(55.10)	(67.77)	(83.96)
	ROIC	0.00	0.00	0.00	0.00	0.00	0.00	0.00	(2,764.51)	(1,445.09)	(3,132.20)
	ROE	(1,539.76)	(384.76)	(126.02)	(141.95)	(120.19)	(65.29)	(72.62)	(70.01)	(84.68)	(106.88)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
NSYS Nortech Systems Incorporated	$29.5M	27.9×	17.5×	+9.34% (above 0%: growing)	−8.33% (below 0%: shrinking)	−1,567.16% (below 0%: shrinking)	17.00%	1.86%	Compare
ITOC iTonic Holdings Ltd.	$29.3M	—	—	—	—	—	—	—	Compare
PMI Flag Ship Acquisition Corp	$23.4M	0.5×	— (loss-making)	+38.62% (above 0%: growing)	n/m	+46.79% (above 0%: growing)	20.85%	(156.70%)	Compare
NSPR InspireMD, Inc.	$22.3M	— (loss-making)	— (loss-making)	−0.39% (below 0%: shrinking)	n/m	−26.00% (below 0%: shrinking)	(43.70%)	(815.64%)
ARAY Accuray Incorporated	$20.8M	— (loss-making)	— (loss-making)	−20.87% (below 0%: shrinking)	n/m	+117.83% (above 0%: growing)	35.22%	5.47%	Compare
MODD Modular Medical, Inc.	$20.5M	— (loss-making)	—	—	n/m	−5.61% (below 0%: shrinking)	0.00%	0.00%	Compare
PAVM PAVmed Inc.	$19.4M	— (loss-making)	— (loss-making)	+450.00% (above 0%: growing)	n/m	−125.63% (below 0%: shrinking)	(269.70%)	(21,278.79%)	Compare
BDMD Baird Medical Investment Holdings Limited	$19.2M	— (loss-making)	—	—	n/m	−598.12% (below 0%: shrinking)	—	—	Compare
LFWD Lifeward Ltd.	$17.2M	— (loss-making)	— (loss-making)	+15.71% (above 0%: growing)	n/m	−52.77% (below 0%: shrinking)	40.90%	(62.69%)	Compare
Median of peers	$20.6M	—	—	+15.71%	—	−52.77%	18.93%	(31.34%)

All 149 Medical Devices stocks →

InspireMD, Inc. (NSPR) key facts

Strength: InspireMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.0 million, up 28.1% from fiscal 2024.
InspireMD, Inc. (NSPR) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, NSPR traded at $0.46, a market capitalization of $22.3 million.
Return on equity was −106.9% and debt-to-equity 0.00.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is −2.61 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.